sbynews

DelMarVa’s Premier Source for Conservative News, Opinion, Analysis, and Human Interest

Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349

The opinions expressed by columnists are their own and do not represent our advertisers

Just In: FDA Panel Rejects Pfizer Booster Shot for Ages 16-65 Over Increased Risk of Heart Inflammation

On Friday, Biden’s vaccination plan hit a major roadblock after an FDA advisory panel declined to endorse authorization the Pfizer-BioNTech Covid booster shot for people aged 16 or older.

The 18 member group of influential experts was tasked with deciding if Pfizer’s latest clinical trials had provided adequate results that demonstrate the safety and effectiveness of their booster shot.

Unsurprisingly, the results did not make the cut, not even close.

The panel voted 16-2 to reject extra doses of experimental vaccine, citing insufficient data from incomplete clinical trials and the potential risk of heart inflammation – especially among young men. 

More

3 thoughts on “Just In: FDA Panel Rejects Pfizer Booster Shot for Ages 16-65 Over Increased Risk of Heart Inflammation”

  1. Do not take the first dose of this poison dart, then you won’t have to worry about boosters and second, third and fourth shots. Please, if you want to live, do not take that awful thing.

Leave a Comment

Your email address will not be published. Required fields are marked *